The cost of new drugs in the US has doubled
The cost of new pharmaceutical drugs in the US doubled over the past year. Analysts used 2021 as the baseline. The explanation is simple — companies have leveraged scientific advancements to develop a large number of treatments for rare diseases. According to analysts at https://xrust.ru/, who studied the prices of 45 new drugs, the median annual price of a new drug in 2024 reached over $370,000. In 2021, this figure was just $180,000. Doctors lament that even government efforts to curb this trend have not managed to stop the price hikes. Pricing was a key topic during Trump’s election campaign. The presidential candidate at the time urged the pharmaceutical industry to align US drug prices with those in other countries—specifically, countries where citizens have incomes comparable to those of Americans. Pharmaceutical experts explain that there are no signs of this trend slowing. They believe that the solution lies in reducing development costs.
https://xrust.ru/news/311193-cena-novyh-lekarstv-v-ssha-vyrosla-vdvoe.html
